Page last updated: 2024-10-18

hydroquinone and Lymphomatoid Papulosis

hydroquinone has been researched along with Lymphomatoid Papulosis in 1 studies

Lymphomatoid Papulosis: Clinically benign, histologically malignant, recurrent cutaneous T-cell lymphoproliferative disorder characterized by an infiltration of large atypical cells surrounded by inflammatory cells. The atypical cells resemble REED-STERNBERG CELLS of HODGKIN DISEASE or the malignant cells of CUTANEOUS T-CELL LYMPHOMA. In some cases, lymphomatoid papulosis progresses to lymphomatous conditions including MYCOSIS FUNGOIDES; HODGKIN DISEASE; CUTANEOUS T-CELL LYMPHOMA; or ANAPLASTIC LARGE-CELL LYMPHOMA.

Research Excerpts

ExcerptRelevanceReference
"Lymphomatoid papulosis is often regarded as a low-grade variant of cutaneous T cell lymphoma (CTCL)."1.48Lymphomatoid papulosis. ( Beasley, JM; Cohen, JM; Latkowski, JM; Meehan, SA; Wiznia, LE, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wiznia, LE1
Cohen, JM1
Beasley, JM1
Meehan, SA1
Latkowski, JM1

Other Studies

1 other study available for hydroquinone and Lymphomatoid Papulosis

ArticleYear
Lymphomatoid papulosis.
    Dermatology online journal, 2018, Dec-15, Volume: 24, Issue:12

    Topics: Aged; Clobetasol; Glucocorticoids; Humans; Hydroquinones; Hyperpigmentation; Lymphomatoid Papulosis;

2018